Judith Dunn, Ph.D.

Judy is currently an Entrepreneur in Residence at Atlas Venture where she focuses on new company creation. During her career, she has held leadership positions in both biotech and large pharma including President of Research and Development at Fulcrum Therapeutics and Global Head of Clinical Development at Hoffmann- La Roche in Basel, Switzerland.  Additional positions in her career included roles in both the research and commercial neuroscience divisions of Pfizer and in clinical psychiatry at Sunovion.  Judy currently serves as an independent director at BioIVT and Evolution Research Group. She holds a bachelor of science degree in neuroscience from the University of Rochester and doctorate in developmental neurobiology from Wesleyan University.